TPC1 regulates melanoma tumourigenesis via mTORC1 and TFEB
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Knocking out TPC1, an endosomal cation channel, suppresses melanoma progression by decreasing mTORC1 activity. This leads to reduced invasiveness and increased pigmentation, highlighting TPC1 as a potential therapeutic target for melanoma.
Area Of Science
- Oncology
- Cell Biology
- Molecular Biology
Background
- Metastatic dissemination and therapy resistance are primary causes of cancer mortality.
- Intratumoral phenotypic heterogeneity, driven by cancer cell-microenvironment interactions, fuels disease progression.
- Mechanistic Target of Rapamycin Complex 1 (mTORC1) activity is crucial for metastatic outgrowth and targeted therapy resistance.
Purpose Of The Study
- To investigate the role of TPC1, an endosomal cation channel, in melanoma progression.
- To elucidate the downstream signaling pathways affected by TPC1 knockout in melanoma cells.
- To identify TPC1 as a potential therapeutic target for melanoma treatment.
Main Methods
- Utilized the murine B16-F0 melanoma cell line for experimental studies.
- Generated TPC1 knockout (KO) melanoma cells.
- Assessed mTORC1 activity, cell proliferation, invasiveness, pigmentation, and transcription factor TFEB localization.
Main Results
- TPC1 knockout significantly decreased mTORC1 activity in melanoma cells.
- TPC1 KO melanoma cells exhibited reduced proliferation and invasiveness.
- Increased pigmentation and nuclear localization of TFEB were observed in TPC1 KO melanoma cells.
Conclusions
- TPC1 knockout induces significant tumor-suppressive effects in melanoma.
- Altered mTORC1 activity and TFEB regulation are key mechanisms underlying TPC1's tumor-suppressive role.
- TPC1 is a critical regulator of melanoma progression and a potential therapeutic target.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...